🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this pilot study is to determine the feasibility, acceptability...
Status
Not Yet Recruiting
Location
Providence Care Hospital
Start Date
2025-01-27
Trial ID
NCT06762522
Triptolide was shown in experimental studies to inhibit the cyst formation ...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2014-04
Trial ID
NCT02115659
Treatments Being Tested
Adverse drug events (ADEs) are the most clinically significant and costly m...
Status
Completed
Location
University of Pittsburgh
Start Date
2012-01
Trial ID
NCT01531088
Treatments Being Tested
This clinical trial is examining the action and effects of several new drug...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2025-06-10
Trial ID
NCT07148739
Treatments Being Tested
The purpose of this study was to assess whether a 6-month multilevel physic...
Status
Completed
Location
University of California, San Diego
Start Date
2011-01
Trial ID
NCT01155011
Management of hemopathies has progressed with the arrival of new drugs such...
Status
Recruiting
Location
Clinique de l'Europe
Start Date
2025-05-22
Trial ID
NCT06713811
Treatments Being Tested
This interventional study investigates the efficacy of dapagliflozin, a sod...
Status
Active Not Recruiting
Location
Al Ahli hospital
Start Date
2025-08-15
Trial ID
NCT07204743
Treatments Being Tested
The objective of this prospective study is to investigate the quality of li...
Status
Recruiting
Location
Alexandra General Hospital
Start Date
2025-02-27
Trial ID
NCT07642362
Treatments Being Tested
Remarkable progress has been made in treating germ-cell tumor (GCT) through...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-11-11
Trial ID
NCT06470464
Treatments Being Tested
Adverse drug events (ADEs) are responsible for 3.6% of the hospitalisations...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2012-05
Trial ID
NCT01610817
Treatments Being Tested